CIP
RDY icon

Convergence Investment Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Convergence Investment Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-395
Closed -$3K – 760
2018
Q1 		$3K Buy
+395
New +$2.77K ﹤0.01% 914

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Convergence Investment Partners's RDY Position: Q2 2018 in Review

Convergence Investment Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2018, closing a stake of 395 shares — an estimated $3K sold.

Convergence Investment Partners first reported a position in RDY in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 137 funds tracked by Wall St. Rank hold RDY as of Q2 2018.

  • Convergence Investment Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 395 Dr. Reddy's Laboratories shares in Q2 2018, an estimated $3K.
  • Convergence Investment Partners first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 1 quarter.
  • Convergence Investment Partners's Dr. Reddy's Laboratories position peaked at $3K in Q1 2018.
  • 137 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.